TrialJAMA oncology2018

Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial.

Vaibhav Sahai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.